JP2014534215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014534215A5 JP2014534215A5 JP2014538834A JP2014538834A JP2014534215A5 JP 2014534215 A5 JP2014534215 A5 JP 2014534215A5 JP 2014538834 A JP2014538834 A JP 2014538834A JP 2014538834 A JP2014538834 A JP 2014538834A JP 2014534215 A5 JP2014534215 A5 JP 2014534215A5
- Authority
- JP
- Japan
- Prior art keywords
- indazol
- composition
- pyrimidinyl
- methylamino
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553454P | 2011-10-31 | 2011-10-31 | |
| US61/553,454 | 2011-10-31 | ||
| PCT/US2012/060361 WO2013066616A1 (en) | 2011-10-31 | 2012-10-16 | Pazopanib formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017093456A Division JP6423484B2 (ja) | 2011-10-31 | 2017-05-10 | パゾパニブ製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014534215A JP2014534215A (ja) | 2014-12-18 |
| JP2014534215A5 true JP2014534215A5 (enExample) | 2015-11-12 |
| JP6200893B2 JP6200893B2 (ja) | 2017-09-20 |
Family
ID=48192602
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014538834A Expired - Fee Related JP6200893B2 (ja) | 2011-10-31 | 2012-10-16 | パゾパニブ製剤 |
| JP2017093456A Expired - Fee Related JP6423484B2 (ja) | 2011-10-31 | 2017-05-10 | パゾパニブ製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017093456A Expired - Fee Related JP6423484B2 (ja) | 2011-10-31 | 2017-05-10 | パゾパニブ製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9278099B2 (enExample) |
| EP (1) | EP2773204A4 (enExample) |
| JP (2) | JP6200893B2 (enExample) |
| KR (1) | KR101993436B1 (enExample) |
| CN (1) | CN104254249B (enExample) |
| AU (1) | AU2012332952B2 (enExample) |
| BR (1) | BR112014010551A2 (enExample) |
| CA (1) | CA2852912A1 (enExample) |
| HK (1) | HK1201685A1 (enExample) |
| IN (1) | IN2014CN02850A (enExample) |
| RU (1) | RU2616500C2 (enExample) |
| WO (1) | WO2013066616A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA201502073B (en) * | 2014-03-28 | 2016-03-30 | Cipla Ltd | Pharmaceutical composition |
| CN110753546B (zh) * | 2017-04-17 | 2023-11-10 | 耶鲁大学 | 治疗或预防急性肺损伤的化合物、组合物和方法 |
| WO2019053500A1 (en) | 2018-04-17 | 2019-03-21 | Alvogen Malta Operations (Row) Ltd | PHARMACEUTICAL COMPOSITION OF SOLID DOSAGE FORM CONTAINING PAZOPANIB AND PROCESS FOR PREPARING THE SAME |
| IL278161B2 (en) | 2018-04-24 | 2024-12-01 | Shionogi & Co | Solid dosage form with excellent stability |
| AU2019259686B2 (en) | 2018-04-24 | 2023-05-25 | Shionogi & Co., Ltd. | Solid formulation having excellent stability |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH675537A5 (enExample) | 1988-03-25 | 1990-10-15 | Ciba Geigy Ag | |
| DE58903964D1 (de) * | 1988-11-10 | 1993-05-06 | Ciba Geigy Ag | Fluessige orale formulierung. |
| EP1343782B1 (en) * | 2000-12-21 | 2009-05-06 | SmithKline Beecham Corporation | Pyrimidineamines as angiogenesis modulators |
| HRP20020923A2 (en) * | 2001-11-23 | 2003-10-31 | Glaxo Group Ltd | Pharmaceutical composition |
| RU2255730C1 (ru) * | 2003-10-14 | 2005-07-10 | Федеральное государственное унитарное предприятие "Всероссийкий научный центр по безопасности биологически активных веществ" (ФГУП "ВНЦ БАВ") | Стабильная фармацевтическая суспензия азитромицина и способ ее получения |
| TWI374883B (en) * | 2004-08-16 | 2012-10-21 | Theravance Inc | Crystalline form of a biphenyl compound |
| TW200740820A (en) * | 2005-07-05 | 2007-11-01 | Takeda Pharmaceuticals Co | Fused heterocyclic derivatives and use thereof |
| US20080293691A1 (en) * | 2005-11-29 | 2008-11-27 | Smithkline Beecham Corporation | Treatment Method |
| ATE500831T1 (de) * | 2005-11-29 | 2011-03-15 | Glaxosmithkline Llc | Krebsbehandlungsverfahren |
| AR059066A1 (es) | 2006-01-27 | 2008-03-12 | Amgen Inc | Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf) |
| US20100267787A1 (en) * | 2007-11-12 | 2010-10-21 | Gregory Harasymiw | Pharmaceutical Compositions |
| CL2008000374A1 (es) * | 2008-02-05 | 2008-04-04 | Igloo Zone Chile S A | Composicion farmaceutica que comprende un polvo para suspension oral de tacrolimus o una de sus sales, hidratos o solvatos y excipientes farmaceuticamente aceptables; procedimiento de preparacion de dicha composicion farmaceutica; y uso para la preve |
| EP2276508A4 (en) * | 2008-04-15 | 2011-12-28 | Sarcode Bioscience Inc | ADMINISTRATION OF LFA-1 ANTAGONISTS TO THE GASTROINTESTINAL SYSTEM |
| WO2010037095A2 (en) * | 2008-09-29 | 2010-04-01 | Nometics | Agents and methods for the treatment of cancer |
| US20100291025A1 (en) | 2009-04-13 | 2010-11-18 | Auspex Pharmaceuticals, Inc. | Indazole inhibitors of tyrosine kinase |
| EP2298321A1 (en) * | 2009-08-26 | 2011-03-23 | Nordic Pharma | Novel pharmaceutical compositions for treating IBD |
| US8501811B2 (en) * | 2010-06-17 | 2013-08-06 | Washington University | TASPASE1 inhibitors and their uses |
-
2012
- 2012-10-16 CN CN201280052742.8A patent/CN104254249B/zh not_active Expired - Fee Related
- 2012-10-16 WO PCT/US2012/060361 patent/WO2013066616A1/en not_active Ceased
- 2012-10-16 BR BR112014010551A patent/BR112014010551A2/pt not_active IP Right Cessation
- 2012-10-16 CA CA2852912A patent/CA2852912A1/en not_active Abandoned
- 2012-10-16 IN IN2850CHN2014 patent/IN2014CN02850A/en unknown
- 2012-10-16 JP JP2014538834A patent/JP6200893B2/ja not_active Expired - Fee Related
- 2012-10-16 EP EP12844715.8A patent/EP2773204A4/en not_active Withdrawn
- 2012-10-16 HK HK15102188.1A patent/HK1201685A1/xx unknown
- 2012-10-16 KR KR1020147014294A patent/KR101993436B1/ko not_active Expired - Fee Related
- 2012-10-16 RU RU2014115289A patent/RU2616500C2/ru active
- 2012-10-16 AU AU2012332952A patent/AU2012332952B2/en not_active Ceased
- 2012-10-16 US US14/353,141 patent/US9278099B2/en active Active
-
2016
- 2016-01-13 US US14/994,497 patent/US10080802B2/en active Active
-
2017
- 2017-05-10 JP JP2017093456A patent/JP6423484B2/ja not_active Expired - Fee Related
-
2018
- 2018-08-22 US US16/109,143 patent/US10596263B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200744677A (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
| JP2014534215A5 (enExample) | ||
| WO2015120110A3 (en) | Novel pharmaceutical formulations | |
| MX2009000035A (es) | Formulaciones de agente activo, procedimientos de preparacion y procedimientos de uso. | |
| SG170047A1 (en) | Nanoparticulate posaconazole formulations | |
| JP2016516765A5 (enExample) | ||
| JP2013525493A5 (enExample) | ||
| DK1553927T3 (da) | Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger | |
| JP2018021007A5 (enExample) | ||
| AR043863A1 (es) | Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines | |
| AR070824A1 (es) | Suspensiones para inyeccion intravitrea de triamcinolona acetonido de baja viscosidad, altamente floculadas | |
| JP2012505172A5 (enExample) | ||
| JP2013535472A5 (enExample) | ||
| FI3943070T3 (fi) | Pitkävaikutteisia bedakiliiniformulaatioita | |
| MX2011005643A (es) | Formas de dosificacion oral de bendamustina. | |
| TW200609001A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconasole | |
| JP2017528497A (ja) | 長時間作用型医薬組成物 | |
| RU2014115289A (ru) | Композиция пазопаниба | |
| JP2016188259A (ja) | 水性眼科組成物 | |
| MX2014001065A (es) | Formulaciones de (trimetoxifenilamino) pirimidilino nuevas. | |
| JP2008538751A5 (enExample) | ||
| RU2007137846A (ru) | Инъецируемые препаративные формы депо и способы обеспечения замедленного высвобождения композиций, состоящих из наночастиц | |
| TW200640459A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconazole | |
| JP2010265261A (ja) | レボカバスチン懸濁型点眼剤 | |
| MA32722B1 (fr) | Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion |